Telehealth giant Ro offers new scale to measure food noise
Telehealth companies have been quick to capitalize on the surge in weight loss drug usage, not only in treating patients with obesity but also in shaping the medical community’s understanding of the condition. One such company making waves in this space is Ro, which recently introduced a new tool aimed at measuring what they term “food noise,” a phenomenon often experienced by individuals struggling with obesity – characterized by constant and overwhelming thoughts about food.
The development of this scale, backed by academic researchers and funded by Ro, is intended to gauge whether treatments can help diminish the level of food noise experienced by patients. This concept has gained traction in recent years, particularly with the emergence of new GLP-1 drugs like Wegovy and Zepbound. Ro is currently using the scale to monitor patients’ progress throughout their treatment journey, and they are also making it available for licensing to pharmaceutical companies for use in clinical trials.
The use of such innovative tools by telehealth companies not only enhances patient care but also contributes to the advancement of obesity treatment and research. By incorporating cutting-edge technologies and methodologies, these companies are revolutionizing the way obesity is perceived and managed within the medical community. As the demand for weight loss solutions continues to grow, telehealth firms are poised to play a significant role in shaping the future of obesity treatment and healthcare delivery.
